Scn2a Dee clinical trials

Explore recruiting scn2a dee clinical trials.

Recruiting scn2a dee studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Scn2a Dee trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy

Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Double-Blind, Randomized Clinical Trial to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of PRAX-562 in Pediatric Participants with Developmental and Epileptic Encephalopathies Followed by an Open-Label Extension

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Scn2a Dee trials by city

Scn2a Dee in Toronto Scn2a Dee in Vancouver Scn2a Dee in Montreal Scn2a Dee in Calgary Scn2a Dee in Edmonton Scn2a Dee in Ottawa Scn2a Dee in Winnipeg Scn2a Dee in Quebec City Scn2a Dee in Hamilton Scn2a Dee in Kitchener Scn2a Dee in London Scn2a Dee in Halifax Scn2a Dee in New York Scn2a Dee in Los Angeles Scn2a Dee in Chicago Scn2a Dee in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease